These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35015183)

  • 1. Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.
    Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Manandhar M; Patt JC; Kneisl JS; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
    Ann Surg Oncol; 2022 May; 29(5):3291-3301. PubMed ID: 35015183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
    Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
    J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
    Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
    BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of the Sarculator and MSKCC nomograms to retroperitoneal sarcoma prognostication in an Asian tertiary center.
    Wong RX; Koh YS; Ong F; Farid M; Tay TKY; Teo M
    Asian J Surg; 2020 Nov; 43(11):1078-1085. PubMed ID: 31941593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
    Mariani L; Miceli R; Kattan MW; Brennan MF; Colecchia M; Fiore M; Casali PG; Gronchi A
    Cancer; 2005 Jan; 103(2):402-8. PubMed ID: 15578681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the Memorial Sloan Kettering Cancer Centre (MSKCC) sarcoma nomogram useful in an Asian population?
    Ng DWJ; Tan GHC; Chia CS; Lim CX; Chee SK; Quek RHH; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e466-e472. PubMed ID: 27869363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry.
    Bagaria SP; Wagie AE; Gray RJ; Pockaj BA; Attia S; Habermann EB; Wasif N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S398-403. PubMed ID: 26353762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
    Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
    Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Stratification with Sarculator and MSKCC in Patients with Primary and Secondary Angiosarcoma.
    Steubing Y; Ahmadi N; Puscz F; Wolff A; Hinzmann J; Reinkemeier F; Schmidt SV; Sogorski A; Von Glinski M; Becerikli M; Füth M; Zuchowski J; Brüggenhorst H; Huyghebaert T; Stricker I; Lehnhardt M; Wallner C
    Life (Basel); 2024 Apr; 14(5):. PubMed ID: 38792591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the
    Lim HJ; Wong R; Koh YS; Ho ZS; Ong CJ; Farid M; Teo CCM
    Front Oncol; 2021; 11():730292. PubMed ID: 34900680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.
    Pasquali S; Colombo C; Pizzamiglio S; Verderio P; Callegaro D; Stacchiotti S; Martin Broto J; Lopez-Pousa A; Ferrari S; Poveda A; De Paoli A; Quagliuolo V; Jurado JC; Comandone A; Grignani G; De Sanctis R; Palassini E; Llomboart-Bosch A; Dei Tos AP; Casali PG; Picci P; Gronchi A
    Eur J Cancer; 2018 Apr; 93():28-36. PubMed ID: 29475197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter.
    Callegaro D; Barretta F; Raut CP; Johnston W; Strauss DC; Honoré C; Bonvalot S; Fairweather M; Rutkowski P; van Houdt WJ; Gladdy RA; Tirotta F; Tzanis D; Skoczylas J; Haas RL; Miceli R; Swallow CJ; Gronchi A
    Ann Surg; 2024 May; 279(5):857-865. PubMed ID: 37753660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
    Gronchi A; Miceli R; Shurell E; Eilber FC; Eilber FR; Anaya DA; Kattan MW; Honoré C; Lev DC; Colombo C; Bonvalot S; Mariani L; Pollock RE
    J Clin Oncol; 2013 May; 31(13):1649-55. PubMed ID: 23530096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
    Pasquali S; Palmerini E; Quagliuolo V; Martin-Broto J; Lopez-Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz-Beveridge R; Ferraresi V; Lugowska I; Infante G; Braglia L; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Miceli R; Casali PG; Gronchi A
    Cancer; 2022 Jan; 128(1):85-93. PubMed ID: 34643947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitotic rate as a prognostic biomarker after preoperative radiotherapy for high-grade limb/trunk soft tissue sarcoma.
    Ouyang Z; Wang T; Brown J; Orosz Z; Trent S; Cosker T; Branford White H; Whitwell D; Guo X; Leonard Maxime Gibbons C
    Radiother Oncol; 2024 Nov; 200():110482. PubMed ID: 39159680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma.
    Tu Q; Hu C; Zhang H; Kong M; Peng C; Song M; Zhao C; Wang Y; Ma X
    Technol Cancer Res Treat; 2021; 20():1533033821997828. PubMed ID: 33706618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall.
    Chadha M; Iadecola S; Jenks A; Pankova V; Tam YB; Burns J; Arthur A; Wilding CP; Chen L; Chudasama P; Callegaro D; Strauss DC; Thway K; Gronchi A; Jones RL; Miceli R; Pasquali S; Huang PH
    Cancer Med; 2024 Jul; 13(14):e70026. PubMed ID: 39041188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.